(IN BRIEF) Eckert & Ziegler, in collaboration with Novartis Pharma K.K., is expanding Ga-68 labeled diagnostics in Japan through a clinical trial approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Utilizing Eckert & Ziegler’s GalliaPharm® generator, the trial … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech, Technology
Tagged clinical research project, clinical trial, computerized Tomography, diagnostics, DOTA-TATE Positron Emission Tomography, Dr. Harald Hasselmann, Eckert & Ziegler, Ga-68, GalliaPharm®, Gallium-68, Ge-68, Japan, Japanese Pharmaceuticals and Medical Devices Agency, NCT06240741, NEN, neuroendocrine neoplasms, Novartis Pharma K.K., PET, PMDA, radioisotope supply, rare tumors
(IN BRIEF) The European Investment Bank (EIB) has signed a €10 million loan agreement with Polish company SDS Optic Inc. to support the development and commercialization of their innovative cancer detection technology platform, inPROBE®. SDS Optic specializes in diagnostic and … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Pharma & Biotech, Poland, Science, Technology
Tagged advanced photonic technologies, biomedical engineering, breast cancer, breast cancer detection device, cancer detection technology, diagnostics, EIB, immunochemistry, inPROBE®, inPROBE® HER2, InvestEU programme, loan, Marcin Staniszewski, Molecular Biology, monitoring devices, Paolo Gentiloni, photonic biosensing, Prof. Teresa Czerwińska, SDS Optic Inc., single cell resolution immunoassay, The European Investment Bank, Warsaw Stock Exchange
HORIZON-RIA PROJECT GRANTED FOR THE EARLY DETECTION OF SEPSIS AT THE POINT-OF-CARE DISRUPTIVE SOLUTION FOR SEPSIS DIAGNOSIS AT THE POINT OF CARE THAT WILL OFFER MULTIPLEXED (WITHIN A SINGLE TEST) (IN BRIEF)The AMBROSIA project has been granted under the call … Read the full press release
Posted in Czech Republic, Education, European Union, France, Greece, Healthcare, Ireland, Netherlands, News, Pharma & Biotech, Science, Spain, Switzerland, Technology, United Kingdom
Tagged AMBROSIA, Argotech, Aristotle University of Thessaloniki, Biopix DNA Technology P.C., Catalan Institute of Nanoscience and Nanotechnology, diagnostics, Dr. Alexandros Pantazis, HORIZON-RIA, intelligent sepsis diagnosis, Ligentec, Microfluidics, microLIQUID, nucleic acids, Optical Sensor, PoC, PoC sepsis diagnostic unit, Point of Care, Prof. Nikos Pleros, SEPSIS, SMART PHOTONICS BV, University of Bourgogne, University of Ioannina, University of Southampton, Vall d'Hebron Research Institute, X-Celeprint
(IN BRIEF) Carus Animal Health and UK medical technology company Attomarker have announced a strategic partnership to develop and commercialize a rapid point of care diagnostic device and multiplex assays for animals. The collaboration will use Attomarker’s Covid Antibody Immunity … Read the full press release
Posted in Healthcare, Management, News, Technology, United Kingdom
Tagged Andrew Shaw, Animal Health, Attomarker, Carus Animal Health, diagnostics, Neil Gow, partnership, Ron Long, University of Exeter
(PRESS RELEASE) PARIS AND MONTPELLIER, 30-Mar-2022 — /EuropaWire/ — ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health). This newly formed European public-private partnership aims at advancing precision … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, European Union, France, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged Alcediag, Alcen, Alexandra Prieux, artificial-intelligence, biomarkers, bipolar, bipolar disorder, blood test, Capital Region of Denmark, depression, diagnostics, EDIT-B Consortium, EIT health, Fundació Clinic per la Recerca Biomèdica, Fundació Sant Joan de Déu, GHU Paris Psychiatrie & Neurosciences, Hospital Clínic de Barcelona, IVD, Jean Marc Bourez, Maurizio Ferrari, mental health, neuropsychiatry, Parc Sanitari Sant Joan de Déu, precision medicine, precision psychiatry, ProductLife Group, Prof. Eduard Vieta, psychiatric disorders, Psychiatry, RNA editing, Synlab, World Bipolar Day
People with moderate or mild haemophilia A have significant unmet clinical needs, as this population may not use preventative treatments due to missed or delayed diagnoses of bleeding episodes and a lack of treatment guidelines1,2 New data indicate that Hemlibra has a favourable safety profile in … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged American Society of Hematology, ASH, bleeding, blood clotting, blood disease, Chugai, Chugai Pharmaceutical, diagnostics, emicizumab, Genentech, haemophilia, Haemophilia A, HAVEN 6, Hemlibra®, Levi Garraway, pharmaceuticals, pharmacodynamics, pharmacokinetics, phase III HAVEN 6 study, prophylactic, Roche
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged advance sequencing technologies, AVENIO Edge System, diagnostic solutions, diagnostics, In Vitro Diagnostics, integrated sequencing, IVD, next-generation sequencing, NGS, Roche, sequencing library preparation, Thomas Schinecker
(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release
Posted in Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged appointment, Assay technologies, Audit Committee, Bioinformatics, biomolecules, diagnostics, DNA, Dr. Toralf Haag, Lawrence Rosen, life sciences, Lonza Group AG, Molecular Diagnostics, QIAGEN, RNA, Sample to Insight, Supervisory Board, Thyssen Handelsunion AG, University of Augsburg, University of Kiel, Voith GmbH & Co. KGaA
LIVERPOOL, 02-Sep-2016 — /EuropaWire/ — A researcher from the University of Liverpool’s Institute of Ageing and Chronic Disease, has published a paper about the challenges faced in introducing new devices and diagnostics into health services. Dr Paul Knox, Reader, Eye and … Read the full press release
Posted in Education, Healthcare, Technology, United Kingdom
Tagged diagnostics, Dr Paul Knox, health services, University of Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
